aspirin
Aspirin (acetylsalicylic acid) is a salicylate that relieves pain and fever and, by dampening platelet clumping, helps prevent heart attacks and strokes. It is one of the oldest medicines still in wide use, both for everyday aches and for cardiovascular protection.
This page is based on MedlinePlus drug information for aspirin, cross-checked with the National Cancer Institute dictionary; the mechanism is explained in plain language, and analogies are used only where they stay accurate.
How it works
Explains what the medicine does in the body, not dosing, side effects, or safety.
An analogy
When tissue is injured, COX enzymes work like small printers churning out flyers - prostaglandins - that summon pain, fever and clotting cells. Aspirin does not just slow the printers; it permanently jams them, so no new flyers are produced until the body builds fresh printers, which in platelets never happens at all.
In simple terms
Pain, fever and inflammation are driven by hormone-like chemicals called prostaglandins, made by enzymes named cyclooxygenases. Aspirin permanently disables these enzymes, so fewer prostaglandins are produced and pain and fever ease. In platelets, the same action stops the making of thromboxane, a chemical that tells platelets to clump, which is why low-dose aspirin helps keep arteries from clogging with clots.
In depth
Acetylsalicylic acid irreversibly acetylates a serine residue in the active site of cyclooxygenase-1 and cyclooxygenase-2, blocking conversion of arachidonic acid to prostaglandin H2. In anucleate platelets, COX-1 cannot be resynthesised, so thromboxane A2 production is suppressed for the platelet's lifespan, producing sustained antiplatelet effect. Endothelial COX-2 inhibition is transient because nucleated cells regenerate the enzyme, sparing much prostacyclin synthesis.
See it in motion
A schematic animation of the mechanism — simplified for clarity, not drawn to scale.
Aspirin turns off the enzyme that makes prostaglandins
- When tissue is injured, COX enzymes work like small printers churning out flyers - prostaglandins - that summon pain, fever and clotting cells.
- Aspirin permanently disables these enzymes, so fewer prostaglandins are produced and pain and fever ease.
- In anucleate platelets, COX-1 cannot be resynthesised, so thromboxane A2 production is suppressed for the platelet's lifespan, producing sustained antiplatelet effect.
- Endothelial COX-2 inhibition is transient because nucleated cells regenerate the enzyme, sparing much prostacyclin synthesis.
Target: Cyclooxygenases (COX-1 and COX-2)
Enzymes that make prostaglandins and thromboxane, the lipid signals behind pain, fever, inflammation and platelet clumping; blocking them quiets all four responses.
Approved uses
Approved uses differ by country and change over time. Always follow your local prescribing information.
Approved uses in United States
FDA- Reduction of fever and relief of mild to moderate pain and inflammation
- Prevention of heart attacks and strokes in people at risk
- Reducing the risk of death in people who are experiencing or who have had a heart attack
Official sources
The statements on this page trace back to these records.
- MedlinePlus: aspirin
MedlinePlus, U.S. National Library of Medicine
- National Cancer Institute: aspirin
National Cancer Institute
This page explains how the medicine works — it isn’t the patient leaflet. For anything that applies to you, read the leaflet that came with your medicine or ask your pharmacist.
MedUnfold provides educational content and is not medical advice. Always follow your local prescribing information and healthcare professional.